
### [NCIT:C7233](http://purl.obolibrary.org/obo/NCIT_C7233)
**Label:** Monomorphic Post-Transplant Lymphoproliferative Disorder

**Subclasses:** [NCIT:C7249](http://purl.obolibrary.org/obo/NCIT_C7249) (Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7238](http://purl.obolibrary.org/obo/NCIT_C7238) (Monomorphic T/NK-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7248](http://purl.obolibrary.org/obo/NCIT_C7248) (Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7237](http://purl.obolibrary.org/obo/NCIT_C7237) (Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7245](http://purl.obolibrary.org/obo/NCIT_C7245) (Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7244](http://purl.obolibrary.org/obo/NCIT_C7244) (Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7247](http://purl.obolibrary.org/obo/NCIT_C7247) (Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7246](http://purl.obolibrary.org/obo/NCIT_C7246) (Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C40562](http://purl.obolibrary.org/obo/NCIT_C40562) (Transformed Neoplastic Lymphocyte) 62.50%
- [NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection) 62.50%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 62.50%
- Thing 51.30%
- [NCIT:C3439](http://purl.obolibrary.org/obo/NCIT_C3439) (Viral Infection) 34.86%
- [NCIT:C36988](http://purl.obolibrary.org/obo/NCIT_C36988) (Neoplastic Lymphocyte) 33.33%
- [NCIT:C36725](http://purl.obolibrary.org/obo/NCIT_C36725) (Abnormal Lymphocyte) 33.16%
- [NCIT:C37060](http://purl.obolibrary.org/obo/NCIT_C37060) (Neoplastic Hematopoietic and Lymphoid Cell) 31.80%
- [NCIT:C12660](http://purl.obolibrary.org/obo/NCIT_C12660) (Reed-Sternberg Cell) 31.40%
- [NCIT:C36987](http://purl.obolibrary.org/obo/NCIT_C36987) (Abnormal Hematopoietic and Lymphoid Cell) 31.02%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 29.57%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 28.51%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 28.34%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.92%
- [NCIT:C37008](http://purl.obolibrary.org/obo/NCIT_C37008) (Neoplastic Large Lymphocyte) 23.16%


